# New LOWER costs for FDA-approved GLP-1s

Canonical: https://brew.new/templates/ro/new-lower-costs-for-fda-approved-glp-1s

Brand: ro.co
Category: newsletter

![Preview of New LOWER costs for FDA-approved GLP-1s](https://cdn.brew.new/email-preview-b4780a77db2c36ac-tracking_r57wmntsmk49e6d6cspk507cbd8f8q4n-1790623274361.png)

## Email content

Ro.Co Icon

Lower prices than your local pharmacy | Get started

Save up to $150/mo on an annual plan

Prepay & Save on Ro today | Get started.

Pay less than the pharmacy on Ro.

Important Safety Information Wegovy (semaglutide) is a prescription medicine for patients with obesity or with overweight, who also have weight-related medical problems, to help them lose weight and maintain weight loss, paired with diet and exercise. Wegovy is also used to reduce the risk of major cardiovascular (CV) events in patients with known CV disease and obesity or overweight. Wegovy is semaglutide and should not be used with other semaglutide-containing products or other GLP-1s. Wegovy may cause serious side effects including possible thyroid tumors and thyroid cancer. Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Wegovy may cause other serious side effects, including pancreatitis, gallbladder problems, increased risk of low blood sugar, kidney problems, serious allergic reactions, changes in vision in patients with type 2 diabetes, increased heart rate, and depression or suicidal thoughts. Tell your provider if you have a planned surgery. For more complete information, including Boxed Warning, visit ro.co/safety

Sexual health

Weight loss

Fertility

Hair loss

Skin care

Daily health

© 2026 Roman Health Ventures,

625 Avenue of the Americas, NY, NY 10011

Contact us

This email was sent to you because you indicated that you'd like to receive marketing and promotional emails from Ro. This email is intended for the recipient only.

Privacy Policy Terms of Service

No longer want to receive these emails?

Unsubscribe

[Open and remix this design](https://brew.new/templates/ro/new-lower-costs-for-fda-approved-glp-1s)

[Browse email designs](https://brew.new/browse/templates)